Why Standard Antidepressants Don't Work for Everyone
Roughly one in three adults with major depression doesn't respond fully to the first two antidepressants they try. That category — treatment-resistant depression — is one of the most frustrating clinical situations in psychiatry, both for the patient living with it and the clinician trying to help. The standard playbook is to layer or rotate SSRIs, SNRIs, atypical antipsychotics, and mood stabilizers, often over months or years, hoping the next combination clicks.
For some patients in Naples and across Southwest Florida, that path eventually works. For others, it doesn't — and the cumulative weight of side effects, partial response, and lost time becomes its own clinical problem. That's the population ketamine therapy was developed for: people who have made a genuine effort with conventional medications, found them insufficient, and need a treatment that works through a different mechanism altogether.
At Uniq Mind, we don't position ketamine as a first-line treatment. We position it as a targeted option for the specific patient who has tried the standard tools and is still looking for relief. The first conversation is always about whether you fit that picture — and what other tools, including pharmacogenomic testing, might explain why prior medications underperformed.
How Ketamine Works Differently
SSRIs and SNRIs work on serotonin and norepinephrine, slowly nudging neurotransmitter levels over weeks. Ketamine works on a different system entirely — the glutamate pathway, specifically NMDA receptors. The clinical signature is also different: where conventional antidepressants take four to eight weeks to show full effect, ketamine often produces a noticeable lift within hours to days of the first dose.
That faster timeline is part of why ketamine has drawn so much attention, especially for patients with active suicidal thinking. It also explains the protocol: typically a short induction series followed by maintenance dosing on a schedule tailored to the individual response. The treatment is not a one-time cure. It's a tool used inside a structured plan that usually still includes therapy, lifestyle work, and often other medications.
The form most commonly used in outpatient psychiatry is intranasal esketamine (Spravato), which is FDA-approved for treatment-resistant depression and depression with acute suicidality. Other forms — IV infusions or sublingual lozenges — exist in different clinical settings. Each delivery method has its own risk profile, monitoring requirements, and insurance coverage picture, and we walk through those tradeoffs honestly during evaluation.
Who Is a Good Candidate?
The typical Uniq Mind ketamine patient has tried at least two adequate trials of conventional antidepressants from different classes without sufficient response. They are medically cleared (blood pressure and cardiac history matter, since ketamine briefly raises both). They are not actively using substances in a way that would complicate treatment, and they have a support system that can drive them home from sessions, since ketamine causes short-term cognitive effects.
What disqualifies a patient is usually not depression severity. It's medical or psychiatric factors — uncontrolled hypertension, certain cardiovascular conditions, current psychotic symptoms, or active substance use disorder — that make the treatment less safe or less likely to help. Pregnancy is also a contraindication. We work through all of this systematically during the initial psychiatric evaluation, which is required before any ketamine protocol begins.
If you're not a candidate for ketamine, that's not a dead end. Other options for treatment-resistant depression — including TMS therapy, deeper medication review with genetic testing, or intensive therapy combined with optimized pharmacology — are part of the same conversation.
What a Course of Treatment Actually Looks Like
The first step is the evaluation visit, which is a full psychiatric assessment, not a quick ketamine intake. We review your treatment history, current symptoms, medical conditions, prior medication trials, and what you're hoping to get out of treatment. If ketamine is appropriate, we explain the specific protocol, monitoring requirements, expected side effects, and what success and non-response would each look like.
The induction phase typically runs twice weekly for several weeks, with each session held in our Naples office under direct medical observation. You arrive, receive the dose, are monitored for about two hours while the acute effects pass, and arrange transportation home. Most patients describe the session itself as a dissociative or dream-like state that resolves within 90 minutes. The antidepressant effect, when it works, accumulates over the first weeks and is then maintained with less frequent dosing.
Throughout treatment we track symptoms with standardized rating scales so the decision to continue, taper, or switch approaches is based on data, not just impressions. If you're not responding by the end of induction, we say so — and we move to a different plan rather than continuing indefinitely.
Where Ketamine Fits in a Broader Mental Health Plan
Ketamine alone, used in isolation, rarely produces lasting change. The patients who do best combine it with therapy — often the same therapy approach that wasn't producing enough movement on its own. The neuroplastic window ketamine creates appears to amplify what good psychotherapy does, which is why many integrative practices, including ours, encourage active therapeutic work during a treatment course.
Lifestyle factors also matter more than people expect. Sleep regulation, alcohol use, exercise, and consistent nutrition all influence response. We don't bury patients in lifestyle homework, but we are honest that a person treating depression with ketamine while sleeping four hours a night and drinking heavily on weekends is fighting an uphill battle.
If you've reached the point of asking whether ketamine therapy could help, the most useful next step is a real conversation — not a sales pitch. The team at Uniq Mind serves patients across Naples and Southwest Florida and offers honest assessments about whether this treatment is likely to help you specifically. Reach us at our Naples office to schedule an evaluation.
